Telix Pharmaceuticals and China Grand Pharma Announce Strategic Licence and Commercial Partnership for Greater China Market

NEXT STORY
European Commission approves Roche’s Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer
PREV STORY
Everest Medicines Announces Approval of Clinical Trial Application by China National Medical Products Administration for Phase 3 Registration Trial of Trodelvy™ for Metastatic Breast Cancer in China
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Espero BioPharma Provides Update on the Development of Tecarfarin for the Treatment of Mechanical Heart Valve Patients in China

JACKSONVILLE, Fla. and IRVINE, Calif., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Espero BioPharma, Inc., ...

author_avatar
NASDAQ Market News

Pharmaceutical Intermediates Market to Outstrip $37,290.33 Million by 2028 Growing Sturdy at 4.2% CAGR – COVID-19 Impact and Global Analysis by TheInsightPartners.com

author_avatar
NASDAQ Market News

Myriad Genetics Announces New Results from Two Large Studies of Its myRisk® Hereditary Cancer Test at American Society of Clinical Oncology

author_avatar
NASDAQ Market News